Aller au contenu principal
Profil bibliographique

Diego Petrilli

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
11Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentHepatitis C virus researchLiver Diseases and ImmunityHeparin-Induced Thrombocytopenia and Thrombosis

Les publications récentes

Accès ouvert 2026 article OpenAlex

Case Report: Borderline type I/II cryoglobulinemia associated with marginal zone lymphoma: a diagnostic challenge

Fabiana Crispo, Giovanna Mansueto, Francesca Pia Scioscia, Massimo Dante Di Somma et autres

Cryoglobulinemia comprises heterogeneous disorders caused by immunoglobulins that precipitate at low temperatures, leading to vascular occlusion and immune-mediated tissue injury. Type I disease is typically linked to monoclonal gammopathies, whereas mixed forms (Type II or III) are characterized by immune complex-mediated vasculitis, …

it, ch (code pays fourni par la source)

0 citations Frontiers in Oncology
2024 conference-abstract OpenAlex

Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre Study

Francesco Autore, Alessandra Tedeschi, Giulia Benevolo, Nicolò Danesin et autres

In the setting of relapsed patients affected by Waldenström Macroglobulinaemia (WM) chemo-immunotherapy (CT) has been substantially substituted by BTKis. Previous trials have investigated efficacy and safety of BTKis in second line without a direct comparison to CT. The aim of our retrospective …

it (code pays fourni par la source)

0 citations Blood
Accès ouvert 2023 conference-abstract OpenAlex

Real-Life Multicentre Study on 547 Patients Affected By Waldenstrom Macroglobulinemia Treated with Chemo-Immunotherapy: Which Is the Best and Most Used First-Line Treatment?

Francesco Autore, Alessandra Tedeschi, Giulia Benevolo, Veronica Mattiello et autres

Waldenström Macroglobulinaemia (WM) is an indolent lymphoma still primarily managed with chemo-immunotherapy, which remains a key first-line treatment option, although recently BTKIs have emerged as potential therapies for untreated patients. The aim of our study was to evaluate and compare efficacy and …

it (code pays fourni par la source)

0 citations Blood

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.